Flourish Research Expands Reach with Strategic Acquisition of CARE

Flourish Research Takes a Bold Step Forward

In a significant move to broaden its operational footprint, Flourish Research has officially acquired the Center for Advanced Research & Education (CARE), a multi-therapeutic research facility dedicated to pioneering healthcare innovations. This acquisition, announced on May 7, 2025, not only strengthens Flourish's capability in conducting clinical trials but also enhances its partnerships with leading pharmaceutical companies.

Founded in 1998 by the accomplished Drs. Chris and Julie Recknor, CARE has established itself as a pillar in the clinical research community. With over 150 diverse clinical trials completed, CARE's dedication to science-driven, patient-focused research has earned it a stellar reputation. This expertise fits seamlessly with Flourish Research's mission, which is centered on cardiovascular, metabolic, neuroscience, and infectious disease studies.

According to Reinhold Schulz, CEO of Flourish, the acquisition of CARE represents an exciting chapter for both organizations. Schulz noted, "Flourish has been highly impressed with CARE's exceptional history of patient engagement across a diverse set of therapeutic areas. We look forward to collaborating with CARE's physician-led leadership team to accelerate our expansion within the oncology market and further cultivate relationships with their prominent pharmaceutical customers. The addition of CARE's state-of-the-art facility also expands Flourish's presence into the Southeast region."

This strategic enlargement is not merely a business maneuver; it is a heartfelt commitment to enhance clinical research capabilities. With CARE's advanced infrastructure and Flourish's expertise, the two entities aim to unlock new possibilities in clinical research at an unprecedented scale. Dr. Chris Recknor expressed enthusiasm for this partnership, stating, "This marks an exciting milestone for CARE and our team as we continue our journey of advancing clinical research to bring life-enhancing therapies to market. By joining forces with Flourish, we unlock opportunities to deliver best-in-class patient care at even greater scale."

Flourish Research, headquartered in Apex, NC, operates a vast network of 27 sites and engages over 152 investigators across various therapeutic areas. This acquisition empowers Flourish to not only serve its biopharma partners more effectively but also to provide a more reliable, efficient patient recruitment experience, characterized by quality and timely results.

The vision shared by both organizations casts a hopeful light on the future of healthcare. Advancements in clinical research can significantly enhance the development of new therapies, impacting countless lives positively. With a combined commitment to excellence, Flourish and CARE are poised to lead the way in groundbreaking clinical trials that will shape the future of medicine.

Financial advisory for CARE during this acquisition was provided by Quadriga Partners, LLC, while Ropes & Gray took care of legal counsel for Flourish. Together, they navigate the complexities of corporate mergers and ensure a smooth transition for both companies.

In conclusion, this acquisition stands as a testament to Flourish Research’s dedication to enhancing healthcare solutions through innovative clinical research. The integration of CARE into Flourish’s operations promises to yield remarkable advancements in patient care and treatment outcomes, reinforcing the importance of collaboration in the healthcare sector. For more information about Flourish Research and their ongoing projects, visit Flourish Research.